The 2025 Commuter Rail Summit is especially well-timed and placed this year. The (CRC) annual convention, which gathers ...
Today, the Government of Canada announced close to $11 million in research infrastructure funding through the Canada Foundation for Innovation (CFI) to ...
While treating non-MSI-high metastatic colorectal cancer remains a challenge, the combination of zanzalintinib and atezolizumab has shown consistent benefits across key subgroups of patients,” said ...
Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced new peer-reviewed data in Practical Laboratory Medicine ...
The Kern County carbon capture project marks California's first commercial CO₂ storage site as legal challenges test its ...
FMC-376 demonstrated robust anti-tumor activity across preclinical models and led to deeper inhibition of KRAS downstream ...
Nearly every song ever written by a Canadian songwriter has already been scraped,’ says music industry witness.
Zacks Investment Research on MSN
California Resources (CRC) Upgraded to Strong Buy: Here's What You Should Know
California Resources Corporation (CRC) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in ...
Laboratory of Neurobiology, Department of Pathology and Experimental Therapy, Institute of Neurosciences, University of Barcelona, Barcelona, Spain ...
Summit Therapeutics Inc. ("Summit," "we," or the "Company") today announced results from the Phase III HARMONi-6 trial, conducted in China and sponsored by our partner, Akeso, Inc. (HKEX Code: 9926.HK ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced landmark results demonstrating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback